Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa

Antimicrob Agents Chemother. 1990 Nov;34(11):2093-6. doi: 10.1128/AAC.34.11.2093.

Abstract

Antagonism between fosfomycin and antipseudomonal penicillins, cefotaxime, and ceftriaxone was observed in Pseudomonas aeruginosa RYC212. Fosfomycin, a non-beta-lactam antibiotic that acts on bacterial cell wall synthesis, decreased the expression of penicillin-binding protein 3 and induced beta-lactamase. The antagonistic effect was reduced in the presence of high concentrations of the beta-lactamase inhibitor tazobactam or in fosfomycin-resistant mutants. We suggest that products resulting from fosfomycin cell wall damage could interact with a system that regulates penicillin-binding protein and beta-lactamase production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Outer Membrane Proteins / metabolism
  • Bacterial Proteins*
  • Carrier Proteins*
  • Cefotaxime / pharmacology
  • Ceftriaxone / pharmacology
  • Fosfomycin / antagonists & inhibitors*
  • Hexosyltransferases / biosynthesis
  • Hexosyltransferases / metabolism*
  • Microbial Sensitivity Tests
  • Multienzyme Complexes / biosynthesis
  • Multienzyme Complexes / metabolism*
  • Muramoylpentapeptide Carboxypeptidase*
  • Penicillin-Binding Proteins
  • Penicillins / pharmacology
  • Peptidyl Transferases / biosynthesis
  • Peptidyl Transferases / metabolism*
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / enzymology
  • Pseudomonas aeruginosa / metabolism*
  • beta-Lactamases / biosynthesis

Substances

  • Anti-Bacterial Agents
  • Bacterial Outer Membrane Proteins
  • Bacterial Proteins
  • Carrier Proteins
  • Multienzyme Complexes
  • Penicillin-Binding Proteins
  • Penicillins
  • Fosfomycin
  • Ceftriaxone
  • Peptidyl Transferases
  • Hexosyltransferases
  • Muramoylpentapeptide Carboxypeptidase
  • beta-Lactamases
  • Cefotaxime